434Prevalence, Risk Factors, and Outcomes of Bacteremia Caused by Carbapenem-resistant Enterobacteriaceae in Neutropenic Patients with Hematologic Malignancies
نویسندگان
چکیده
434. Prevalence, Risk Factors, and Outcomes of Bacteremia Caused by Carbapenem-resistant Enterobacteriaceae in Neutropenic Patients with Hematologic Malignancies Michael J. Satlin, MD, MS; Nina Cohen, PharmD; Kevin C. Ma, MD; Zivile Gedrimaite; Thomas J. Walsh, MD, FIDSA; Susan K. Seo, MD; Internal Medicine/Infectious Diseases, Weill Cornell Medical College, New York, NY; Memorial Sloan-Kettering Cancer Center, New York, NY; Internal Medicine, New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, NY; Infectious Diseases Service, Memorial Sloan-Kettering Cancer Center, New York, NY; New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, NY; Infectious Disease Service, Memorial Sloan-Kettering Cancer Center, New York, NY
منابع مشابه
Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis
BACKGROUND It is unknown whether there are differences between bacteremia caused by carbapenem resistant Acinetobacter baumannii (CRAB) and carbapenem resistant Acinetobacter nosocomialis (CRAN). This study aims to investigate the differences, especially in clinical outcomes, between patients with bacteremia caused by CRAB or CRAN. METHODS This is a 9-year retrospective study comparing the cl...
متن کاملThe outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies.
BACKGROUND Febrile neutropenia (FN) is generally a complication of cancer chemotherapy. OBJECTIVES We retrospectively evaluated the febrile neutropenia episodes and their outcomes with respect to modification rates of non-carbapenem-based empirical antibacterial therapy and vancomycin-resistant enterococcus (VRE) colonisation that caused to VRE bacteremia in patients with hematological malign...
متن کاملBloodstream infections in patients with hematological malignancies: which is more fatal – cancer or resistant pathogens?
BACKGROUND The primary objective of this study was to report the incidence of bloodstream infections (BSIs) and clinically or microbiologically proven bacterial or fungal BSIs during neutropenic episodes in patients with hematological malignancies. METHODS In this retrospective observational study, all patients in the hematology department older than 14 years who developed febrile neutropenia...
متن کاملThe global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.
Carbapenem-resistant Enterobacteriaceae (CRE) are emerging global pathogens. The spread of CRE to transplant recipients and patients with hematologic malignancies has ominous implications. These patients rely on timely, active antibacterial therapy to combat gram-negative infections; however, recommended empirical regimens are not active against CRE. Approximately 3%-10% of solid organ transpla...
متن کاملCarbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias
BACKGROUND Carbapenem-resistant Klebsiella pneumoniae (CRKP) spread and infections in patients with haematological malignancies are a serious concern especially in endemic areas. Treatment failures and delay in appropriate therapy for CRKP infections are frequent and the mortality rate associated with CRKP bacteremia in neutropenic haematological patients is reported about 60%. METHODS Haemat...
متن کامل